Literature DB >> 14561921

Involvement of apolipoprotein E in glioblastoma: immunohistochemistry and clinical outcome.

James A R Nicoll1, Elena Zunarelli, Roy Rampling, Lilian S Murray, Vakis Papanastassiou, Janice Stewart.   

Abstract

We hypothesised that apolipoprotein E (apoE) influences brain tumours by delivery of lipids to tumour cells and by analogy with other brain insults. APOE gene analysis was performed for 126 glioblastomas, the commonest primary brain tumour. Neither APOE epsilon2 nor epsilon4 alleles were significantly associated with differences in post-operative survival. However, there was apoE immunoreactivity of tumour cells, macrophages in areas of necrosis and astrocytes nearby. The immunohistochemistry findings support the hypothesis that apoE is involved in the delivery of lipids to tumour cells and in the recycling of lipids by macrophages in necrotic areas, raising the possibility that apoE-mediated lipid transport may represent a new therapeutic target in brain tumours.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14561921     DOI: 10.1097/00001756-200310270-00008

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.

Authors:  Meena U Rajagopal; Yetrib Hathout; Tobey J MacDonald; Mark W Kieran; Sri Gururangan; Susan M Blaney; Peter Phillips; Roger Packer; Heather Gordish-Dressman; Brian R Rood
Journal:  Proteomics       Date:  2011-01-27       Impact factor: 3.984

2.  Effect of 10 different polymorphisms on preoperative volumetric characteristics of glioblastoma multiforme.

Authors:  Christian Henker; Thomas Kriesen; Katharina Fürst; Deborah Goody; Änne Glass; Brigitte M Pützer; Jürgen Piek
Journal:  J Neurooncol       Date:  2015-11-25       Impact factor: 4.130

3.  Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics.

Authors:  Maxime S Heroux; Marla A Chesnik; Brian D Halligan; Mona Al-Gizawiy; Jennifer M Connelly; Wade M Mueller; Scott D Rand; Elizabeth J Cochran; Peter S LaViolette; Mark G Malkin; Kathleen M Schmainda; Shama P Mirza
Journal:  Physiol Genomics       Date:  2014-05-06       Impact factor: 3.107

4.  Association of the apolipoprotein E 2 allele with concurrent occurrence of endometrial hyperplasia and endometrial carcinoma.

Authors:  Tatiana I Ivanova; Ludmila I Krikunova; Nikolay I Ryabchenko; Liana S Mkrtchyan; Vera A Khorokhorina; Lyubov E Salnikova
Journal:  Oxid Med Cell Longev       Date:  2015-02-09       Impact factor: 6.543

5.  Mechanisms of enhanced antiglioma efficacy of polysorbate 80-modified paclitaxel-loaded PLGA nanoparticles by focused ultrasound.

Authors:  Yingjia Li; Manxiang Wu; Nisi Zhang; Caiyun Tang; Peng Jiang; Xin Liu; Fei Yan; Hairong Zheng
Journal:  J Cell Mol Med       Date:  2018-06-29       Impact factor: 5.310

Review 6.  Apolipoproteins and cancer.

Authors:  Liwen Ren; Jie Yi; Wan Li; Xiangjin Zheng; Jinyi Liu; Jinhua Wang; Guanhua Du
Journal:  Cancer Med       Date:  2019-10-01       Impact factor: 4.452

7.  Ultrasound-responsive nutlin-loaded nanoparticles for combined chemotherapy and piezoelectric treatment of glioblastoma cells.

Authors:  Carlotta Pucci; Attilio Marino; Özlem Şen; Daniele De Pasquale; Martina Bartolucci; Nerea Iturrioz-Rodríguez; Nicoletta di Leo; Giuseppe de Vito; Doriana Debellis; Andrea Petretto; Gianni Ciofani
Journal:  Acta Biomater       Date:  2021-04-21       Impact factor: 8.947

8.  Ferroptosis-Related APOE, BCL3 and ALOX5AP Gene Polymorphisms are Associated with the Risk of Thyroid Cancer.

Authors:  Zhifu Xiao; Haixia Zhao
Journal:  Pharmgenomics Pers Med       Date:  2022-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.